Open AccessEt tu Mucor?
Author(s) -
Anadi Khatri,
Gunjan Prasai,
Mukesh Pandey,
Muna Kharel,
Dikshya Bohara,
Madhav Panthi,
Najara Thapa,
Bhaskar Jha,
Eli Pradhan
Publication year - 2021
Publication title -
nepalese journal of ophthalmology
Language(s) - English
Resource type - Journals
eISSN - 2091-0320
pISSN - 2072-6805
DOI - 10.3126/nepjoph.v13i2.39751
Subject(s) - mucormycosis , medicine , covid-19 , indian subcontinent , intensive care medicine , pathology , disease , history , ancient history , infectious disease (medical specialty)
Recently, the Indian subcontinent has been hard hit by the second wave of COVID-19. Along with it, the region has become a hot spot for mucormycosis infection in patients with COVID-19. The aim of this paper is to provide a scientific overview on the status of mucormycosis in pre-COVID-19 era and on how COVID-19 could have directly or indirectly expose the hidden burden of mucormycosis globally.Materials and methods: This paper is structured as a narrative review and is based on relevant published literature on both COVID-19 and mucormycosis. Conclusion: Mucormycosis in the pre-COVID-19 era was almost a neglected entity. It was because the risk factors for both - More severe COVID-19 infections and Mucormycosis are almost similar – COVID-19 might have helped to expose the true magnitude of the mucormycosis and flagging it as a major public health concern requiring a revisit by medical science.